Skip to contentS
Surgery Partners, Inc.
S
SGRYSurgery Partners, Inc. Q1 2026 · 10-Q
Revenue$810.90M$810.90M+4.5% vs Q1 2025 Net Income-$35.90M-$35.90MN/M vs Q1 2025 EPS Diluted-$0.28-$0.28N/M vs Q1 2025 Operating Income$65,800,000+6.3% Operating Cash Flow
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Surgery Partners, Inc. · CIK 1638833 · Engraved from SEC EDGAR
Free Cash Flowderived-$4,300,000N/M Margins · derivedOperating margin8.1%+0.1 pt vs Q1 2025
Net margin-4.4%+0.4 pt vs Q1 2025
ended Mar 31, 2026 · filed May 5, 2026 · 35 d after period end